v3 Chapter 764： Another future giant got it

When it comes to the acquisition of stocks of listed companies, Polaris Capital must have a dedicated financial investment department.

Apart from Xia Yu, no one in the company is more suitable than the future Wall Street investment guru Peter Lynch to build the financial investment department.

Peter Lynch can only work harder, while taking care of the overall work, he spends a little time thinking about his own business.

The formation of multiple departments at the same time and the preparation of the acquisition plan for Abbott have made Polaris Capital run at a high speed.

The preliminary work of the acquisition is destined to take some time, which is not worthy of Xia Yu's attention.

But he was not lazy, and he was ready to hurry up, and at the same time he started working on Abbott. The target was Dr. George B. Ratman, the founder of Amgen.

But he didn't know this big cow, so he came to Genentech and found Professor Herb Boyle in the laboratory.

"Professor Herb Boyle, do you know Dr. George B. Ratman at Abbott?"

Professor Herb Boyle turned off the faucet, dried the water in his hand with a towel, and looked at Xia Yu in doubt: "Of course I know that he is very good in the field of blood and tumors. We have also discussed in depth together, Mr. Xia. , Did you ask him for anything?"

Xia Yu nodded slightly and said: "Yes, I think he is a very good scientist. If his research can be realized, it will benefit the world. I want to talk to him. Can you recommend me?"

Professor Herb Boyle suddenly said with a smile: "Of course it's okay. I think Dr. George B. Ratman will be surprised."

"Of course, I can't think of any reason why he can refuse, after all, every scientist wants to be able to complete his own research!"

"Mr. Xia, I will contact him first, and I will tell you if I am sure, are you free during this time?"

Xia Yu nodded and said, "I'm free anytime, I'll trouble you!"

"No trouble, it's a matter of effort!"

...

Two days later, in a secluded coffee shop in San Francisco, Xia Yu met Dr. George B. Ratman, who was about 40 years old.

After leading Xia Yu to meet him, Professor Herb Boyle chatted with Dr. George B. Ratman and left early.

His task has been completed. As for the chat between Xia Yu and Dr. George B. Latman, he felt it was inconvenient to listen, and his time was also precious.

"Dr. Ratman, nice to meet you, my name is Xia Yu and I am the chairman of Polaris Capital!"

"Hello, Mr. Xia!"

After shaking hands and saying hello, the two sat down face to face, and then ordered a cup of coffee.

Xia Yu took the lead and said, "Dr. Ratman, I think Professor Herb Boyle should have told you something before, right?"

Thinking of what Professor Herb Boyle told him when he found him before, Dr. George B. Ratman was slightly excited, nodded and said, "Yes, he told me something."

In fact, when Professor Herb Boyle found him yesterday and told him about this, he was very excited, and he felt stunned by a pie falling from the sky.

God knows how much he envied Professor Herb Boyle when he learned that Polaris Capital had acquired Genentech. He didn't expect that the **** of luck would come to him soon.

And looking at Dr. Ratman’s expression, Xia Yu also had a certain bottom in his heart, stating: "Dr. Ratman, I have a certain understanding of you. You have deep research in blood and tumors. Now in the world Scientists in China are far from exploring these two fields. Countless people have lost their claims because of blood diseases and malignant tumors. I hope I can do something for this world."

"I listed many scientists in these two fields, but in the end, I chose you for the time being. I think you can also be like Professor Herb Boyle. What do you think?"

Xia Yu said this because he didn't want to be too eager to prevent George B. Ratman from having extra thoughts and affecting his interests.

George B. Ratman looked solemn and thanked Xia Yu before saying: "Mr. Xia, I am honored to be recognized by you. I have done some research on blood and tumors, and I have also proposed to Abbott. I have applied, but unfortunately I did not get enough funds."

"I would love to cooperate with you, but before that, I want to hear your plan."

Xia Yu smiled and nodded: "Of course, it should be."

"We will register and establish a biotechnology company and then hire you as the head of scientific research, but you will own the company's equity. As for the shareholding ratio, it will be negotiated based on the value provided by both of us. What do you think?"

After speaking, Xia Yu smiled and looked at Dr. George B. Ratman, who frowned slightly.

Xia Yu didn’t want to engage in venture capital, because he knew the value of Dr. George B. Ratman’s head, so he wanted to tie up Dr. George B. Ratman’s amount and also own pharmaceutical companies as much as possible. More equity.

He is not short of money at all. If, like Genentech, a venture capital of 100,000 U.S. dollars at its establishment, a small amount of equity, and then again and again to spend large amounts of money to raise funds, this is the least worthwhile.

After all, George B. Ratman is different from Professor Herb Boyle, because when the latter founded the company, he was already a Nobel Prize winner, possessed certain patents, and was highly sought after by capital.

But George B. Latman is different. Although he is famous, he is not too big. It is definitely not as good as Nobel Prize winners. Secondly, he has no patents. It is only in blood and blood. The field of oncology has gone far.

Different strengths lead to different confidence in the negotiations.

That's why Xia Yu came up with this plan.

It is even more a joke to agree on the equity based on the value provided by both parties. George B. Latman, who has not yet come up with a patent, will definitely be at a disadvantage. The equity that can be obtained will not be too much, but he has to be tied to the company.

Xia Yu's heart is black!

Xia Yu’s words made George B. Latman gradually calm his heart. He carefully considered the meaning of Xia Yu’s words, and after thinking for a long time, did he pluck up the courage to ask: "Mr. Xia, why can’t you talk to Genentech Is it the same?"

Xia Yu spread his hand and said confidently: "Dr. George B. Latman, you may not know much about us at Polaris Capital. We are not such a small character. If we are not humble, we are not short of money and time. Is the most precious."

"Do you want to slow down the progress of research due to the poor conditions of scientific research at the beginning?"

"Your age at this time is the peak period of your life. I personally think that you should clear all obstacles for you and be able to devote yourself to research. We are willing to gamble for you!"

When he said this, Xia Yu's eyes were burning, and he looked directly into George B. Ratman's eyes.

George B. Ratman looked solemn, his thoughts were struggling from gains and losses, and he thought of the dilemma of insufficient funds he had repeatedly faced when he was at Abbott, and his original intention to engage in scientific research.

After a long time, he calmed down and looked at Xia Yu and said, "Mr. Xia, you are right. For me, time is the most precious Just follow your plan, and thank you. Recognition of me! I will do my best not to let you suffer losses!"

Xia Yu smiled, got up and stretched out his hand to Dr. George B. Ratman, who also got up and held Xia Yu's hand tightly.

"Then, I wish us a happy cooperation!"

"Happy cooperation!"

...

Dr. George B. Ratman is also the character of Lei Lingfeng, and he also has his own professional ethics. Now that he has decided, he immediately submitted a letter of resignation to Abbott, and then fully negotiated with Polaris Capital.

The content of the negotiation is very complicated, including but not limited to the amount of investment, equity allocation, company location, etc.

After three days, all the content was negotiated.

The new company was finally determined to be Amgen, Polaris invested 19 million US dollars as the company’s start-up capital, and Dr. George B. Latman invested in shares at his own value for one million US dollars.

Amgen’s total value is 20 million U.S. dollars. Polaris holds 95% of the shares and Dr. George B. Ratman holds 5% of the shares.

As for the location of the company, San Francisco was not chosen, but Thousand Oaks, California, with a strong academic atmosphere, which is close to the University of California and California Institute of Technology.

After the company was registered, 19 million US dollars of funds were immediately credited to the company's account, and Dr. George B. Ratman rushed to Thousand Oaks with enthusiasm to start planning and building his own laboratory.

Another biopharmaceutical company with great potential has arrived!

As long as Dr. George B. Ratman remains stupid under better conditions, then this investment will definitely not lose!

PS: Ask for tickets and book all, thank you!

https://

Please remember the domain name of this book's first publication:. Apex novel mobile version reading URL: